The Food and Drug Administration on Thursday approved the first ever over-the-counter birth control daily pill, a major development amid a heightened debate over contraception in the wake of the Supreme Court’s momentous decision last summer to overturn Roe v. Wade.
The FDA approved Opill for nonprescription use.
The FDA approved norgestrel, marketed as Opill, the agency announced in a statement.
Patrizia Cavazzoni, FDA drug evaluation and research director, said the approval makes the pill available for millions of Americans, calling the contraception “safe and expected to be more effective” than available nonprescription contraceptive methods.
This is a developing story and will be updated.
Roe V. Wade Overturned One Year On: Here’s Where The Money’s Going (Forbes)
Mifepristone: Supreme Court Keeps Abortion Pills Legal—At Least For Now—Blocking Ruling (Forbes)